Intensive blood glucose control, intensive blood pressure control, renin-angiotensin system blockade with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), dietary protein restriction, and lipid-lowering therapy contribute to diminishing the risk of diabetic nephropathy [25,26,27]. The gene discussed is ACE; the disease is diabetic kidney disease.